Cabio Biotech(wuhan)co.,ltd

Cabio Biotech(wuhan)co.,ltd


Company description

CABIO Bioengineering (Wuhan) Co Ltd (CABIO), is a hi-tech venture jointly founded by Wuhan Alking Bioengineering Co Ltd.and Cargill Incorporated. It has two wholly-owned subsidiaries in Gedian and Jiangxia respectively.

CABIO is the first company in China to engage in the production of unsaturated fatty acid with fermentation technology;which mainly serves ARA and Docosahexaenoic acid derived from microalga(DHA algal oil) and other high-end food ingredients; is the leading brand in the ARA industry in China; is the only Chinese company whose ARA products have been approved as the NOVEL FOOD by European Commission and as GRAS by the U.S. FDA. We have taken the leading role in drafting state standards for food safety regarding ARA and DHA (with the fermentation method); and have two advanced plants manufacturing ARA and DHA monomers currently.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Fat Replacers |Flavour Enhancers |Nutrients More

Upcoming events

3 dec 2019

Fi Europe & Ni 2019

3 - 5 December 2019 Paris, France Visit us at stand 7N144 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

3 oct 2018

Fi Asia 2018

3 -5 October 2018 Jakarta, Indonesia We were at stand D1.Q12 See our Exhibitor Profile   See full Exhibitor List
28 nov 2017

Fi Europe & Ni 2017

28 - 30 November 2017 Messe Frankfurt, Germany We were at stand 11.1A61 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Cabio Biotech(wuhan)co.,ltd

Cabio Biotech(wuhan)co.,ltd

Contact information




View all contact information